MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aquinox Pharmaceuticals Company Profile (NASDAQ:AQXP)

Consensus Ratings for Aquinox Pharmaceuticals (NASDAQ:AQXP) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $20.33 (219.20% upside)

Analysts' Ratings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016Needham & Company LLCInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Leerink SwannLower Price TargetOutperform$26.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Jefferies GroupReiterated RatingHold$19.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Cowen and CompanyReiterated RatingBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Canaccord GenuityReiterated RatingBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015GuggenheimInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q1($0.35)($0.39)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q4($0.37)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2015Q315($0.45)($0.43)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.56)($0.44)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2015Q115($0.83)($0.60)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/15/2015($0.57)($0.78)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015($0.76)($0.78)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014($0.29)($0.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.27)($0.51)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Aquinox Pharmaceuticals (NASDAQ:AQXP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.38)($0.31)($0.35)
Q2 20162($0.47)($0.42)($0.45)
Q3 20162($0.53)($0.45)($0.49)
Q4 20162($0.59)($0.49)($0.54)
(Data provided by Zacks Investment Research)
Dividend History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/16/2016Bros. Advisors Lp BakerMajor ShareholderBuy471,667$7.99$3,768,619.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Bros. Advisors Lp BakerMajor ShareholderBuy109,912$7.98$877,097.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2016Bros. Advisors Lp BakerMajor ShareholderBuy140,786$10.80$1,520,488.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2016Bros. Advisors Lp BakerMajor ShareholderBuy112,034$9.48$1,062,082.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Bros. Advisors Lp BakerMajor ShareholderBuy78,045$9.11$710,989.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Bros. Advisors Lp BakerMajor ShareholderBuy202,623$8.28$1,677,718.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2015Bros. Advisors Lp BakerMajor ShareholderBuy2,480,032$15.50$38,440,496.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015David Chilton MitchellVPBuy3,575$17.81$63,670.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Kamran AlamCFOSell29,079$18.67$542,904.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Lloyd MackenzieVPSell35,887$18.67$670,010.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014& Johnson JohnsonMajor ShareholderSell8,100$7.62$61,722.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014& Johnson JohnsonMajor ShareholderSell5,000$7.51$37,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014& Johnson JohnsonMajor ShareholderSell8,300$7.72$64,076.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014& Johnson JohnsonMajor ShareholderSell5,000$7.73$38,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014& Johnson JohnsonMajor ShareholderSell2,000$7.69$15,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2014& Johnson JohnsonMajor ShareholderSell15,900$7.76$123,384.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014& Johnson JohnsonMajor ShareholderSell1,200$7.54$9,048.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014& Johnson JohnsonMajor ShareholderSell2,000$7.75$15,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014& Johnson JohnsonMajor ShareholderSell9,500$8.14$77,330.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014Pfizer IncMajor ShareholderBuy272,727$11.00$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Aquinox Pharmaceuticals (NASDAQ:AQXP)
DateHeadline
06/28/16 02:47 PMCovering the Bases on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Where is the Stock Going? - Press Telegraph
06/28/16 02:47 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Reviewing Stock Performance - Press Telegraph
06/28/16 02:47 PMMonitoring Target Price Consensus for: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
06/28/16 02:47 PMFocus Stock Recap for: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
06/27/16 02:53 PMWatching Stock Sentiment for:Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
06/27/16 07:18 AMAquinox Pharmaceuticals, Inc. (AQXP) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 02:33 PMAquinox Pharmaceuticals Incorporated (NASDAQ:AQXP) Short Interest Decreased By 13.08% - Press Telegraph
06/25/16 02:33 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Update on Stock Performance - Press Telegraph
06/24/16 02:32 PMAquinox Pharmaceuticals, Inc. (AQXP) Updated Price Targets - FTSE News
06/24/16 02:32 PMImpact Score Outlook on:Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
06/19/16 07:17 AMAquinox Pharmaceuticals, Inc. (AQXP) Analyst Price Targets For The Coming Week - Fiscal Standard
06/06/16 01:32 PMAquinox Pharmaceuticals, Inc. :AQXP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 -
06/04/16 07:54 PMTarget Price Review Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - HNN
06/04/16 02:34 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Stock Performance Recap - HNN
06/03/16 08:38 PMActive Stock in Focus : Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - HNN
06/03/16 02:38 PMSentiment Score Update: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - HNN
06/03/16 11:01 AMBroker Watchlist: Aquinox Pharmaceuticals, Inc. (AQXP) - Share Trading News
06/02/16 08:33 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Near Term Target Update - Stock Tick Tock - Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Near Term Target UpdateStock Tick TockSell-siders covering shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) have a consensus price target of $14 for the next 12-18 months. Analysts study the companies they cover in order to present the sell-side institutions with the information ...and more »
06/02/16 02:38 PMStock Review and Earnings Check on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - HNN - Stock Review and Earnings Check on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) to report quarterly EPS of $-0.44. The company's next earnings report is expected to be ...and more »
06/02/16 02:38 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Rundown on Share Performance - HNN - Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Rundown on Share PerformanceHNNIn the latest trading period, Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) shares have seen a change of +3.61%. During the period, the stock has moved up to a high of $8.77 and dipped to a low of $8.10. Looking at a broader view of stock performance, ...and more »
06/01/16 02:35 PMActive Stock Review: Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - HNN - Active Stock Review: Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP)HNNRecent trading activity of Aquinox Pharmaceuticals Inc.(NASDAQ:AQXP) gets the stock on the active list for today. Shares have changed 0.98% since the open at the time of writing. After a recent look, the stock had hit $8.28. Company shares have been ...and more »
06/01/16 10:59 AMShare Rating Focus on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - HNN - Share Rating Focus on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 1.75 on shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP). Covering analysts ...
06/01/16 08:15 AMAquinox to Present at Jefferies 2016 Healthcare Conference - [GlobeNewswire] - VANCOUVER, British Columbia, June 01, 2016-- Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and ...
05/31/16 08:15 PMStock Performance Check on : Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - HNN - Stock Performance Check on : Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP)HNNTracking share activity in recent trading action, shares of Aquinox Pharmaceuticals Inc. have been recorded 493.12% away from the 52 week low. Company shares have been recently seen -85.32% off of the 52 week high. The stock has been trading at ...and more »
05/31/16 08:15 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock Update & Estimates - Stock Tick Tock - Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) to post earnings of $-0.44 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be ...and more »
05/31/16 02:37 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Review of Stock Performance - HNN - Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Review of Stock PerformanceHNNDuring the most recent trading session, shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) have moved +7.97%. During the period, shares have moved to a high of $8.39 and fell to a low of $7.57. Broadening the view, the stock has range traded from ...and more »
05/30/16 09:02 PMStock Performance Review : Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - HNN - Stock Performance Review : Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP)HNNShares of Aquinox Pharmaceuticals Inc.(NASDAQ:AQXP) have been recently seen at -86.28% away from the 52 week high and 454.35% separated from the 52 week low. If we move in a bit closer, the stock has been recently recorded at -31.08% away from ...and more »
05/30/16 09:02 PMPrice Target in View Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - HNN - Price Target in View Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)HNNAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) has been provided a consensus price target of $14 on shares. Out of all the Wall Street analysts polled by Zacks Research that were included for this target, the analyst with the highest price target sees the ...and more »
05/28/16 12:35 PMView on Earnings Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - HNN - View on Earnings Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)HNNSell-side analysts that cover Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) are expecting the company to report earnings for the quarter of $-0.44. The consensus estimate uses covering analysts polled by Zacks Research. The estimate may vary from what ...
05/26/16 12:39 PMInsiders Are Gradually Buying Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - Wall Street Hints and News - Insiders Are Gradually Buying Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) have increased their position in the stock by 4.05% over the past 6 months. Insiders now own 78.93% of total outstanding shares. There are both legal and ...and more »
05/26/16 12:39 PMEarnings Review and Stock Rundown for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Wall Street Hints and News - Earnings Review and Stock Rundown for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)Wall Street Hints and NewsEarnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) to post quarterly EPS of $-0.44. The company is expected to next publish earnings on or ...and more »
05/25/16 08:36 AMAquinox Announces Executive Appointments - [at noodls] - 92b74688-35c1-4186-b0f3-a9458fc3d2db.pdf May 25, 2016 VANCOUVER, British Columbia, May 25, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical ...
05/24/16 12:02 PMAquinox Pharmaceuticals Incorporated (NASDAQ:AQXP) Shorts Decreased by 0.42% After Short Covering - Wall Street Hints and News - Aquinox Pharmaceuticals Incorporated (NASDAQ:AQXP) Shorts Decreased by 0.42% After Short CoveringWall Street Hints and NewsOut of 5 analysts covering Aquinox Pharma (NASDAQ:AQXP), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. Aquinox Pharma has been the topic of 5 analyst reports since September 11, 2015 according to StockzIntelligence Inc.and more »
05/24/16 12:02 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Share Performance Update - Wall Street Hints and News - Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Share Performance UpdateWall Street Hints and NewsIn the latest session, shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) saw a move of +4.67%. During the session, the stock touched a high of $7.24 and saw a low of $6.81. Shares of the company have been recently recorded -29.00% away from the ...and more »
05/23/16 01:39 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Slapped with $14 Target Price - Wall Street Hints and News - Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Slapped with $14 Target PriceWall Street Hints and NewsThe sell-side consensus on the Street is anticipating that shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) reach $14. This is the mean estimate compiled by weighing in the analyst targets tracked by Zack's research. The top estimate is as high as ...and more »
05/23/16 01:39 PMStock Seeing Heavy Trading Activity: Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - Wall Street Hints and News - Stock Seeing Heavy Trading Activity: Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP)Wall Street Hints and NewsAquinox Pharmaceuticals Inc. (NASDAQ:AQXP) are changing hands this session as it is listed on the most active list for the day. A recent tick puts the equity 2.55% from the opening price. After a recent check, the stock price had reached $6.84. Company ...and more »
05/23/16 01:39 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock Impact Update - Wall Street Hints and News - Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock Impact UpdateWall Street Hints and NewsStock traders might be interested in keeping tabs on news and sentiment scores across the internet. Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) has been given an impact score of 0. The impact score is offered to provide current insight on how the stock ...and more »
05/21/16 11:24 AMRevenue Update on Aquinox Pharmaceuticals Inc(NASDAQ:AQXP) - Trade Calls - Revenue Update on Aquinox Pharmaceuticals Inc(NASDAQ:AQXP)Trade CallsAquinox Pharmaceuticals Inc(NASDAQ:AQXP) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 10, 2016. Earnings per share were $-0.39. Analysts had estimated an EPS of $-0.35. In a different note ...
05/20/16 11:46 AMCheck on Impact Score :Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Wall Street Hints and News - Check on Impact Score :Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)Wall Street Hints and NewsTraders may be interested in tracking company sentiment and impact scores. Currently, Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) has been given an impact score of 0. The impact score is offered to provide current insight on how the stock might ...and more »
05/18/16 08:15 AMAquinox to Present at 2016 Annual UBS Global Healthcare Conference - [GlobeNewswire] - VANCOUVER, British Columbia, May 18, 2016-- Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and ...
05/16/16 01:58 PMAquinox Pharmaceuticals, Inc. (AQXP) Broker Price Targets For The Coming Week - Share Trading News - Aquinox Pharmaceuticals, Inc. (AQXP) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Aquinox Pharmaceuticals, Inc. (AQXP). The latest reports which are currently in issue on Sunday 15th of May state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
05/15/16 05:47 AMFocusing in on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Global Operations) sold 651 shares at $149.55 per share price.Also, On Mar 1, 2016, Heidi L Wagner (SVP, Global Government Affairs) sold 547 shares at $138.91 per share price.On Mar 1, 2016, Saqib Islam (EVP, Chief Strat & Port. (NASDAQ:ALNY). The latest ...
05/13/16 05:55 AMAquinox Pharmaceuticals, Inc. (AQXP) Updated Broker Price Targets - Share Trading News - Aquinox Pharmaceuticals, Inc. (AQXP) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Aquinox Pharmaceuticals, Inc. (AQXP). The latest reports which are currently in issue on Thursday 12th of May state 0 analysts have a rating of “strong buy”, 0 analysts ...Needham Thinks Aquinox Pharmaceuticals' Stock is Going to RecoverAnalyst Ratingsall 3 news articles »
05/11/16 03:17 PMAQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/11/16 05:25 AMConsensus Rating Review for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - B.O.D.Y Confidential - Consensus Rating Review for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1.75 on shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a ...and more »
05/10/16 08:07 AMAQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements -
05/10/16 08:03 AMAQUINOX PHARMACEUTICALS, INC Files SEC form 10-Q, Quarterly Report -
05/10/16 05:47 AMNext Weeks Broker Price Targets For Aquinox Pharmaceuticals, Inc. (AQXP) - Share Trading News - Next Weeks Broker Price Targets For Aquinox Pharmaceuticals, Inc. (AQXP)Share Trading NewsAquinox Pharmaceuticals, Inc. has a 50 day moving average of 9.04 and a 200 day moving average of 10.80. The stock's market capitalization is 132.35M, it has a 52-week low of 1.38 and a 52-week high of 55.75. The share price of the company (AQXP) was ...Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock WatchNews TribuneAquinox Pharmaceuticals Incorporated (NASDAQ:AQXP) Shorted Shares Increased 3.65% After Market SellingThe Postall 4 news articles »
05/05/16 08:17 AM9:17 am Aquinox Pharma to present results of the Phase 2 LEADERSHIP 201 trial with AQX-1125 in patients with IC/BPS at the American Urological Association Annual Meeting from May 6-10 -
05/04/16 03:57 AMAverage Analyst Rating for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - B.O.D.Y Confidential - Average Analyst Rating for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1.75 on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks ...and more »
About Aquinox Pharmaceuticals

Aquinox Pharmaceuticals logoAquinox Pharmaceuticals, Inc., formerly Aquinox Pharmaceuticals (USA) Inc., is a clinical stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Aquinox Pharmaceuticals (Canada) Inc. is a wholly owned subsidiary of the Company. The primary focus of the Company is anti-inflammatory product candidates targeting SHIP1, which is a regulator of a cellular signaling pathway in immune cells, known as the PI3K pathway. Its lead product candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The Company has completed multiple preclinical studies and clinical trials with AQX-1125, it is advancing through Phase II development in several initial indications. The Company operates in Vancouver, British Columbia, Canada.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AQXP
  • CUSIP:
Key Metrics:
  • Previous Close: $6.16
  • 50 Day Moving Average: $7.1646
  • 200 Day Moving Average: $9.2220
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $109.78M
  • Current Quarter EPS Consensus Estimate: $-1.7900 EPS
Additional Links:
Aquinox Pharmaceuticals (NASDAQ:AQXP) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha